pharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis and treatment of alcohol use disorders, alzheimer's, anemia, anxiet Read More

Classification Information

Class [005]
Pharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis and treatment of alcohol use disorders, Alzheimer's, anemia, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, hormonal diseases and disorders, namely vasomotor symptoms and hot flashes, inflammation and inflammatory diseases and disorders, namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, namely metabolic syndrome, migraines, muscle diseases and disorders, namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders, namely Huntington's disease, Alzheimer's disease, Dementia and Parkinson's disease, neurological disorders namely, Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, pain relief, pancreatic diseases and disorders, psychiatric disorders, namely acute stress disorder, substance abuse, delusions and hallucinations, reproductive system diseases and disorders, namely uterine fibroids, endometriosis, benign prostatic hyperplasia and polycystic ovarian syndrome, sleep disorders, urological disorders; antipsychotic pharmaceutical preparations; antidepressants; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases; Pharmaceutical preparations for the diagnosis and treatment of cancer; pharmaceutical preparations, namely monoclonal antibody regulating angiogenesis

Classification kind code

Mark Details

Serial Number

1793429

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 50 on 29^th Mar 2018	Allowed
Submitted for opposition 51 on 29^th Mar 2018	Allowance Notice Sent
Submitted for opposition 42 on 13^th Dec 2017	Advertised
Submitted for opposition 26 on 23^rd Nov 2017	Approved
Submitted for opposition 27 on 06^th Oct 2017	Approval Notice Sent
Submitted for opposition 22 on 17^th Feb 2017	Search Recorded
Submitted for opposition 20 on 17^th Feb 2017	Examiner's First Report
Submitted for opposition 31 on 03^rd Aug 2016	Formalized
Submitted for opposition 1 on 29^th Jul 2016	Created
Submitted for opposition 30 on 27^th Jul 2016	Filed